Sean A. Power, CPA — Chief Financial Officer at TG Therapeutics | Comparably
TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval by several foreign nations for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn. BRIUMVI® is a registered trademark of TG Therapeutics, Inc. read more
EMPLOYEE
PARTICIPANTS
31
TOTAL
RATINGS
639
HR or Marketing? Claim Your Free Employer Account
Sean A. Power, CPA — Chief Financial Officer at TG Therapeutics

Sean A. Power, CPA — Chief Financial Officer at TG Therapeutics

Executive Bio

Sean A. Power, CPA, has served as the Company’s Chief Financial Officer since December 2011. Mr. Power joined the Company from Keryx Biopharmaceuticals, Inc. (KERX), where he served as Corporate Controller from 2006 to 2011. During his tenure there, Mr. Power was involved in all capital raising and licensing transactions. He was also responsible for leading Keryx’s compliance with Securities and Exchange Commission rules and regulations. Prior to joining Keryx, he was with KPMG, LLP, independent certified public accountants, where he served as a senior associate. Mr. Power received a BBA in accounting from Siena College and is a member of the American Institute of Certified Public Accountants.

Executive Team Culture Ratings from TG Therapeutics Employees

TOP
20%
TG Therapeutics' Executive Team scores in the Top 20%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Experience - 3 to 6 Years 77/100
Gender - Female 71/100
Ethnicity - Caucasian 68/100
Who ranks the Executive Team the lowest?
Experience - 1 to 3 Years 40/100
Gender - Male 42/100
Department - All Industries 46/100

TG Therapeutics' Executive Team at a Glance

Based on 29 ratings, TG Therapeutics' employees are satisfied with their Executive Team and give them a “B+” or 77/100. On average, Women provided higher ratings for their Executive Team compared to Men.

TG Therapeutics' Executive Team ranks in the Top 15% of other companies in Burlington, NC and Top 20% of other companies on Comparably that also have 201-500 Employees.

×
Rate your company